Standout Papers

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephr... 2001 2026 2009 2017 4.2k
  1. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes (2001)
    Edmund J. Lewis, Lawrence G. Hunsicker et al. New England Journal of Medicine
  2. Tolvaptan, a Selective Oral Vasopressin V 2 -Receptor Antagonist, for Hyponatremia (2006)
    Robert W. Schrier, Peter Groß et al. New England Journal of Medicine
  3. The Syndrome of Inappropriate Antidiuresis (2007)
    David H. Ellison, Tomás Berl New England Journal of Medicine

Immediate Impact

2 by Nobel laureates 1 from Science/Nature 109 standout
Sub-graph 1 of 12

Citing Papers

Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
2024 Standout
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants
2023 Standout

Works of Tomás Berl being referenced

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes
2001 Standout

Author Peers

Author Last Decade Papers Cites
Tomás Berl 2778 4427 4124 4516 151 13.1k
Murray Epstein 1693 2602 2714 4940 257 12.9k
David C. Wheeler 2428 2329 6497 2684 266 15.3k
Stephen C. Textor 1894 6485 3288 4863 279 17.2k
Kimio Tomita 3456 2315 3135 2673 192 11.1k
Leopoldo Raij 1987 1710 4394 5688 196 14.3k
Timothy W. Meyer 2679 1536 6327 2285 137 11.7k
Akira Hishida 2158 2121 4581 2698 297 13.2k
Carl Erik Mogensen 1193 1276 6077 4843 209 12.9k
Hans‐Henrik Parving 1844 1384 6014 7647 122 17.2k
Rajiv Agarwal 937 1717 4257 4632 226 10.4k

All Works

Loading papers...

Rankless by CCL
2026